8,676 Shares in LeMaitre Vascular, Inc. (NASDAQ:LMAT) Purchased by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 8,676 shares of the medical instruments supplier’s stock, valued at approximately $728,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Segall Bryant & Hamill LLC grew its holdings in shares of LeMaitre Vascular by 29.4% in the 1st quarter. Segall Bryant & Hamill LLC now owns 76,460 shares of the medical instruments supplier’s stock worth $6,415,000 after acquiring an additional 17,354 shares during the last quarter. Victory Capital Management Inc. increased its stake in LeMaitre Vascular by 45.9% in the 1st quarter. Victory Capital Management Inc. now owns 79,871 shares of the medical instruments supplier’s stock worth $6,701,000 after purchasing an additional 25,133 shares in the last quarter. Mutual of America Capital Management LLC lifted its stake in LeMaitre Vascular by 6.1% during the first quarter. Mutual of America Capital Management LLC now owns 35,331 shares of the medical instruments supplier’s stock valued at $2,964,000 after buying an additional 2,038 shares in the last quarter. Alps Advisors Inc. acquired a new position in shares of LeMaitre Vascular in the first quarter worth about $354,000. Finally, Linden Thomas Advisory Services LLC boosted its holdings in shares of LeMaitre Vascular by 3.2% in the first quarter. Linden Thomas Advisory Services LLC now owns 35,591 shares of the medical instruments supplier’s stock worth $2,986,000 after buying an additional 1,109 shares during the period. 84.64% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Barrington Research restated a “market perform” rating on shares of LeMaitre Vascular in a report on Tuesday, July 22nd. Five investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $97.83.

LeMaitre Vascular Stock Down 0.2%

LeMaitre Vascular stock opened at $81.04 on Friday. The firm’s 50 day moving average price is $82.52 and its two-hundred day moving average price is $86.87. The firm has a market cap of $1.83 billion, a PE ratio of 40.93, a P/E/G ratio of 2.14 and a beta of 0.79. LeMaitre Vascular, Inc. has a twelve month low of $71.42 and a twelve month high of $109.58. The company has a debt-to-equity ratio of 0.48, a quick ratio of 13.83 and a current ratio of 16.49.

LeMaitre Vascular (NASDAQ:LMAT) last posted its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $0.48 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.02). LeMaitre Vascular had a return on equity of 13.53% and a net margin of 19.96%. The company had revenue of $59.87 million during the quarter, compared to analyst estimates of $57.61 million. During the same period last year, the company posted $0.44 earnings per share. The company’s revenue was up 12.0% compared to the same quarter last year. On average, research analysts predict that LeMaitre Vascular, Inc. will post 1.94 EPS for the current fiscal year.

Insider Buying and Selling at LeMaitre Vascular

In other news, CEO George W. Lemaitre sold 4,399 shares of LeMaitre Vascular stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $85.10, for a total transaction of $374,354.90. Following the completion of the sale, the chief executive officer directly owned 1,827,003 shares in the company, valued at $155,477,955.30. The trade was a 0.24% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Over the last three months, insiders sold 100,000 shares of company stock worth $8,556,857. 9.50% of the stock is owned by company insiders.

LeMaitre Vascular Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.